冷凍アブレーション装置の世界市場：洞察、競合情勢、市場予測：2030年

世界の冷凍アブレーション装置の市場規模は、2024年から2030年までの予測期間中に8.8％のCAGRで拡大すると予測されています。冷凍アブレーション装置の需要は、主に心血管障害を患う患者数の増加、がんなどの慢性疾患を患う患者数の増加、冷凍アブレーション用にカスタマイズされたプローブのより高い利用可能性、冷凍アブレーション装置に関連する技術進歩の増加によって後押しされており、2024年から2030年までの予測期間中に全体的な市場成長に貢献するとみられています。

冷凍アブレーション装置市場は、さまざまな要因によって製品需要が増加しています。重要な要因の1つは、がん患者の増加です。世界のがん罹患率の増加は、がん治療における冷凍アブレーション装置の使用による冷凍アブレーション装置需要の増加に起因しています。世界保健機関（WHO）が発表した2020年のデータでは、世界中で約1,000万人ががんに苦しんでいます。

また、上記の情報源によると、最も一般的ながんの種類には、乳がん、結腸がん、肺がん、直腸がん、前立腺がんなどがあります。

さらに、GLOBOCAN Statistics 2020によると、2020年には全世界で推定1,930万人のがん患者が新たに発生し、うち1,810万人はメラノーマ以外の皮膚がん、約1,000万人はがんによる死亡です。

また、上記出典によると、女性の乳がんは肺がんを抜き、最も多く診断されるがんとなっており、その数は230万人（11.7％）、次いで肺がん（11.4％）、大腸がん（10％）、前立腺がん（7.3％）、胃がん（5.6％）と推定されています。

さらに、2022年の全米保健統計によると、米国では約189万8,160人が新たにがんを発症し、60万8,570人が死亡しています。

当レポートでは、世界の冷凍アブレーション装置市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 冷凍アブレーション装置市場レポートのイントロダクション

第2章 冷凍アブレーション装置市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 冷凍アブレーション装置市場の主な要因分析

• 冷凍アブレーション装置市場の促進要因
• 冷凍アブレーション装置市場の抑制要因と課題
• 冷凍アブレーション装置市場の機会

第5章 冷凍アブレーション装置市場におけるポーターのファイブフォース分析

第6章 冷凍アブレーション装置市場に対するCOVID-19の影響分析

第7章 冷凍アブレーション装置の市場概要

• 製品タイプ別
• 用途別
• エンドユーザー別
• 地域別

第8章 冷凍アブレーション装置市場における企業と製品プロファイル

• Medtronic
• CPSI BIOTECH
• Coopersurgical Inc.
• Atricure, Inc.
• Galil Medical Inc.
• BVM Medical Limited
• Healthtronics, Inc.
• SANARUS TECHNOLOGIES
• METRUM CRYOFLEX SP
• Boston Scientific Corporation
• Varian Medical Systems, Inc.
• Biosense Webster
• Adagio Medical
• Icecure Medical

第9章 KOL の見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Cryoablation devices Market in Global (2021-2030)
• Table 4: Cryoablation devices Market in Global by Product Type (2021-2030)
• Table 5: Cryoablation devices Market in Global by Application (2021-2030)
• Table 6: Cryoablation devices Market in Global by End User (2021-2030)
• Table 7: Cryoablation devices Market in North America by Country (2021-2030)
• Table 8: Cryoablation devices Market in the US (2021-2030)
• Table 9: Cryoablation devices Market in Canada (2021-2030)
• Table 10: Cryoablation devices Market in Mexico (2021-2030)
• Table 11: Cryoablation devices Market in Europe by Country (2021-2030)
• Table 12: Cryoablation devices Market in France (2021-2030)
• Table 13: Cryoablation devices Market in Germany (2021-2030)
• Table 14: Cryoablation devices Market in the United Kingdom (2021-2030)
• Table 15: Cryoablation devices Market in Italy (2021-2030)
• Table 16: Cryoablation devices Market in Spain (2021-2030)
• Table 17: Cryoablation devices Market in Russia (2021-2030)
• Table 18: Cryoablation devices Market in Rest of Europe (2021-2030)
• Table 19: Cryoablation devices Market in China (2021-2030)
• Table 20: Cryoablation devices Market in Japan (2021-2030)
• Table 21: Cryoablation devices Market in India (2021-2030)
• Table 22: Cryoablation devices Market in Australia (2021-2030)
• Table 23: Cryoablation devices Market in South Korea (2021-2030)
• Table 24: Cryoablation devices Market in Rest of APAC (2021-2030)
• Table 25: Cryoablation devices Market in Rest of the World (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Cryoablation devices Market in Global (2021-2030)
• Figure 4: Cryoablation devices Market in Global by Product Type (2021-2030)
• Figure 5: Cryoablation devices Market in Global by Application (2021-2030)
• Figure 6: Cryoablation devices Market in Global by End User (2021-2030)
• Figure 7: Cryoablation devices Market in North America by Country (2021-2030)
• Figure 8: Cryoablation devices Market in the US (2021-2030)
• Figure 9: Cryoablation devices Market in Canada (2021-2030)
• Figure 10: Cryoablation devices Market in Mexico (2021-2030)
• Figure 11: Cryoablation devices Market in Europe by Country (2021-2030)
• Figure 12: Cryoablation devices Market in France (2021-2030)
• Figure 13: Cryoablation devices Market in Germany (2021-2030)
• Figure 14: Cryoablation devices Market in the United Kingdom (2021-2030)
• Figure 15: Cryoablation devices Market in Italy (2021-2030)
• Figure 16: Cryoablation devices Market in Spain (2021-2030)
• Figure 17: Cryoablation devices Market in Russia (2021-2030)
• Figure 18: Cryoablation devices Market in Rest of Europe (2021-2030)
• Figure 19: Cryoablation devices Market in China (2021-2030)
• Figure 20: Cryoablation devices Market in Japan (2021-2030)
• Figure 21: Cryoablation devices Market in India (2021-2030)
• Figure 22: Cryoablation devices Market in Australia (2021-2030)
• Figure 23: Cryoablation devices Market in South Korea (2021-2030)
• Figure 24: Cryoablation devices Market in Rest of APAC (2021-2030)
• Figure 25: Cryoablation devices Market in Rest of the World (2021-2030)
• Figure 26: Market Drivers
• Figure 27: Market Barriers
• Figure 28: Marker Opportunities
• Figure 29: PORTER'S Five Force Analysis

Cryoablation Devices Market By Product Type (Tissue Contact Probe Ablators, Epidermal And Subcutaneous Cryoablation Systems, And Tissue Spray Probe Ablators), By Application (Prostate Cancer, Renal Cancer, Liver Cancer, Breast Cancer, Lung Cancer, And Cardiac Arrhythmia), By End-Users (Hospitals, Ambulatory Surgical Centers, And Speciality Clinics) And by geography is estimated to register appreciable CAGR forecast till 2030 owing to the increasing prevalence of chronic diseases such as cancer, rising number of cardiovascular cases and the higher availability of customzied probes for the purpose of cryoablation among others

Global cryoablation devices market is estimated to advance at a CAGR of 8.8% during the forecast period from 2024 to 2030. The demand for cryoablation devices is primarily being boosted by the rising number of patients suffering from cardiovascular disorders, the increase in the number of patients suffering from chronic disorders such as cancer, higher availability of customized probes for cryoablation, the increasing technological advancements associated with the cryoablation devices will help in contributing in the overall market growth of the cryoablation devices during the forecast period from 2024-2030.

Cryoablation Devices Market Dynamics:

The cryoablation devices market is experiencing increasing product demand owing to a variety of factors. One of the important factors is the growing prevalence of patients affected with cancer. The rising prevalence of cancer across the globe can be attributed to increase the demand of cryoablation devices owing to the use of cryoablation devices in the treatment of cancer. As per the data published by the World Health Organization 2020, there were approximately 10 million people suffering from cancers across the world.

Also as per the above mentioned source, the most common cancer types include breasts, colon, lung, rectum and prostate cancers.

Furthermore, as per the GLOBOCAN Statistics 2020, worldwide an estimated 19.3 million new cancer cases, including 18.1 million excluding non-melanoma skin cancer and approximately 10 million cancer deaths had occurred in the year 2020.

Also, as per the above source, female breast cancers had surpassed lung cancer as the most commonly diagnosed cancer, with an estimated number of 2.3 new million cases (11.7%), followed by lung (11.4%), colorectal (10%), prostate (7.3%), and stomach (5.6%).

Furthermore, as per the National Health Statistics, 2022, approximately 1,898,160 new cancer cases and 608,570 cancer deaths had occurred in the United States.

Moreover, as per the GLOBOCAN Europe 2020, the number of new cases in breast cancer in the year 2020 were estimated to be 531 086 and about 519 820 people suffered from colorectal cancer.

The cryoablation devices are used for killing the cancer cells with extreme levels of cold, thus, the rising number of chronic conditions such as cancer could contribute to the Cryoablation Devices market growth in the region.

Furthermore, the rising number of patients affected with cardiovascular diseases will also increase the demand of cryoablation devices, leading to an increase in the overall market growth of the cryoablation devices. According to the World Health Organization 2022, in the year 2023, cardiovascular diseases are the leading cause of death globally affecting about 17.9 million people every year.

However, the lack of skilled and trained professionals and the concerns related to the safety of the cryoablation devices may restrict the cryoablation devices market growth.

The cryoablation devices market has been affected slightly after the emergence of the COVID-19 infections. Due to the outbreak of the COVID-19 pandemic, the market for Cryoablation Devices witnessed slow growth. This is due to the delay in the number of elective procedures during the pandemic. Moreover, temporary shutdown of clinics due to nationwide lockdown, disruption in supply because of logistical restrictions imposed at the time of COVID-19 wave, and hospitals shifting their focus towards COVID management also affected the Cryoablation Devices demand. However, the launch of various vaccines and mass vaccination drives have resume normal operations further leading to the growth of the Cryoablation Devices market during the post-pandemic.

Cryoablation Devices Market Segment Analysis:

Cryoablation devices Market by Product Type (Tissue Contact Probe Ablators, Epidermal and Subcutaneous Cryoablation Systems, Tissue Spray Probe Ablators), by Application (Prostate Cancer, Renal Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Cardiac Arrhythmia), by End-Users (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the cryoablation devices market, the tissue contact probe ablators category is expected to amass a significant share in the market revenue during the forecast period. This can be ascribed to various factors such as the rising prevalence of cardiovascular diseases such as atrial fibrillation and cardiac arrythmia, rising product approvals pertaining to tissue contact probe ablators devices, rising research and development associated with the tissue contact probe ablators devices that are extensively used in delivering the ablating energy to the tissue in contact. A tissue contact probe ablators is a specialized surgical device is widely used during surgeries. The instrument provides several advantages when performing the cryoablation procedure during the surgical process. Apart from that, the instruments help the practitioners in attaining a steady and reliable ablation efficiency. The tissue contact probe is quick when it comes to achieving lethal temperatures and maintaining that same temperature consistently across the probe length. Owing to an increase in the advantages offered by the tissue contact probe ablators, there will be an increase in the demand of the tissue contact probe ablators, leading to an overall increase in the cryoablation devices market growth.

Furthermore, the increase in number of product approvals will also lead to an increase in the demand of tissue contact probe ablators, leading to an overall rise in the cryoablation devices market growth. For instance, on December 23, 2020, the United States Food and Drug Administration had approved AtriCure's CryoICE cryo-ablation probe.

Thus, all the aforementioned factors are likely to propel the tissue contact probe ablators category growth in the cryoablation devices market during the forecast period.

North America is expected to dominate the overall Cryoablation Devices Market:

Among all the regions, North America is estimated to account for the largest share in the cryoablation devices market. Owing to significance of key growth factors such as prevalence of chronic diseases as cardiovascular diseases and cancers across the region, rising research and development owing to the increasing prevalence of chronic disorders, increasing usage of cryoablation devices, the rising availability of customized probes pertaining to cryoablation, growing approvals for Cryoablation devices in the North American region coupled with increasing focus of the government in terms of providing access to healthcare services has also helped the market growth in this region.

For instance, according to the National Institute of Health, in the year 2020, an estimated number of 1,806,590 new cases of cancer were diagnosed in the United States and about 606,520 people were affected from the disease.

Furthermore, as per the Centers for Disease Control and Prevention, 2022, in the United States in 2018, 1,708,921 new cancer cases were reported and about 599,265 people were affected with cancer.

Moreover, according to the American Cancer Society Inc. 2022, there were about 268,490 new cases of prostate cancer and about 34,500 people were affected from prostate cancers in the United States.

Also, as per the American Society of Clinical Oncology (ASCO), 2022, an estimated 81,180 adults (61,700 men and 19,480 women) in the United States were diagnosed with bladder cancer.

Also, as per the same source, American Cancer Society, 2022, about 236,740 new cases of lung cancer (117,910 in men and 118,830 in women) were diagnosed in the year 2020 and about 130,180 people were affected from lung cancers in 2020 in the United States. Thus, all the above mentioned factors will lead to an increase in the North America cryoablation devices market.

Cryoablation Devices Market Key Players:

Some of the key market players operating in the cryoablation devices market includes Medtronic, CPSI BIOTECH, Coopersurgical Inc., Atricure, Inc., Galil Medical Inc., Bvm Medical Limited, Healthtronics, Inc., SANARUS TECHNOLOGIES, METRUM CRYOFLEX SP, Boston Scientific Corporation, Varian Medical Systems, Inc., Biosense Webster, Adagio Medical, Icecure Medical, and others.

Recent Developmental Activities in Cryoablation Devices Market:

On February 21, 2022, Medtronic had bagged the US FDA approval for Freezor and Freezor Xtra Cardiac Cryoablation catheters.

On November 10, 2022, Medtronic India had launched the cryoablation catheter, Arctic Front Cardiac Cryoablation Catheter system for the treatment of atrial fibrillation patients.

On June 21, 2022, Medtronic had received the FDA expanded approval for Arctic Front family of cardiac cryoablation catheters for the initial use of recurrent symptomatic paroxysmal atrial fibrillation.

On April 29, 2020, the IceCure's ProSense system, a cryoablation device used to destroy cancerous tissue, had been approved for use in India.

Key Takeaways from the Cryoablation Devices Market Report Study

• Market size analysis for current cryoablation devices market size (2023), and market forecast for 5 years (2024-2030).
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the cryoablation devices market.
• Top key product/services/Technology developments, merger, acquisition, partnership, joint venture happened for last 3 years.
• Key companies dominating the Global cryoablation devices Market.
• Various opportunities available for the other competitor in the Cryoablation devices Market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current cryoablation devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for cryoablation devices market growth in the coming future?

Target Audience who can be benefited from this Cryoablation Devices Market Report Study

• Cryoablation devices market products providers
• Research organizations and consulting companies
• Cryoablation devices market -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Cryoablation devices market
• Various End-users who want to know more about the Cryoablation devices market and latest technological developments in the Cryoablation devices market.

Frequently Asked Questions for Cryoablation Devices Market:

1. What are Cryoablation devices Market?

Cryoablation for cancer is a treatment to kill cancer cells with extreme cold. During cryoablation, a thin, wandlike needle (cryoprobe) is inserted through the skin and directly into the cancerous tumour. A gas is pumped into the cryoprobe in order to freeze the tissue. Then the tissue is allowed to thaw. The freezing and thawing process is repeated several times during the same treatment session.

2. What is the market for Global Cryoablation devices Market?

Global cryoablation devices market is estimated to advance at a CAGR of 8.8% during the forecast period from 2024 to 2030.

3. What are the drivers for Global Cryoablation devices Market?

The demand for cryoablation devices is primarily being boosted by increasing prevalence of cancers, rising prevalence of cardiovascular disorders, rising technological advancements pertaining to the cryoablation devices, and the rising geriatric population susceptible to developing chronic disorders thereby contributing in the overall growth of the cryoablation devices market during the forecast period from 2024-2030.

4. Who are the key players operating in Global Cryoablation devices Market?

Some of the key market players operating in the cryoablation devices market includes Medtronic, CPSI BIOTECH, Coopersurgical Inc., Atricure, Inc., Galil Medical Inc., Bvm Medical Limited, Healthtronics, Inc., SANARUS TECHNOLOGIES, METRUM CRYOFLEX SP, Boston Scientific Corporation, Varian Medical Systems, Inc., Biosense Webster, Adagio Medical, Icecure Medical, and others.

5. Which region has the highest share in Cryoablation devices Market?

North America is expected to dominate the overall Cryoablation devices Market during the forecast period, 2024 to 2030. Owing to significance of key growth factors such as rising prevalence of cardiovascular diseases and cancer, growing technological advancements pertaining to the cryoablation devices, rising geriatric population susceptible to developing chronic disorders with the rising focus of the government in terms of providing access to healthcare solutions catering to such indications, the North America cryoablation devices market is expected to witness positive growth.

Table of Contents

1.Cryoablation devices Market Report Introduction

2.Cryoablation devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Cryoablation devices Market Key Factors Analysis

• 4.1. Cryoablation devices Market Drivers
  • 4.1.1. Rising Incidence of cancer
  • 4.1.2. Growing number of cardiovascular disorders
  • 4.1.3. Higher availability of customized probes for cryoablation
• 4.2. Cryoablation devices Market Restraints and Challenges
  • 4.2.1. Lack of training or skilled professionals to operate cryoablation systems
  • 4.2.2. Increasing concerns regarding the safety of cryoablation procedures
• 4.3. Cryoablation devices Market Opportunities
  • 4.3.1. Rising number of atrioventricular nodal re-entrant tachycardia (AVNRT) procedures for the treatment of cancer
  • 4.3.2. Growing awareness about the cryoablation device in the healthcare sector

5. Cryoablation devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Cryoablation devices Market

7. Cryoablation devices Market Layout

• 7.1. By Product Type
  • 7.1.1. Tissue Contact Probe Ablators
  • 7.1.2. Epidermal and Subcutaneous Cryoablation Systems
  • 7.1.3. Tissue Spray Probe Ablators
• 7.2. By Application
  • 7.2.1. Prostate Cancer
  • 7.2.2. Renal Cancer
  • 7.2.3. Liver Cancer
  • 7.2.4. Breast Cancer
  • 7.2.5. Lung Cancer
  • 7.2.6. Cardiac Arrhythmia
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Surgical centres
  • 7.3.3. Specialty Clinics
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America Cryoablation devices Market, by Country
    • 7.4.1.1.1. United States
    • 7.4.1.1.2. Canada
    • 7.4.1.1.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe Cryoablation devices Market, by Country
    • 7.4.2.1.1. France
    • 7.4.2.1.2. Germany
    • 7.4.2.1.3. United Kingdom
    • 7.4.2.1.4. Italy
    • 7.4.2.1.5. Spain
    • 7.4.2.1.6. Russia
    • 7.4.2.1.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific Cryoablation devices Market, by Country
    • 7.4.3.1.1. China
    • 7.4.3.1.2. Japan
    • 7.4.3.1.3. India
    • 7.4.3.1.4. Australia
    • 7.4.3.1.5. South Korea
    • 7.4.3.1.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)

8. Cryoablation devices Market Company and Product Profiles

• 8.1. Medtronic
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. CPSI BIOTECH
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Coopersurgical Inc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Atricure, Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Galil Medical Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. BVM Medical Limited
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Healthtronics, Inc.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. SANARUS TECHNOLOGIES
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. METRUM CRYOFLEX SP
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Boston Scientific Corporation
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Varian Medical Systems, Inc.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Biosense Webster
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Adagio Medical
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Icecure Medical
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us